Emily Lau Kui Ling is a Senior Lecturer at the Department of English Language, Faculty of Languages and Linguistics, University of Malaya.  Her core research domains include Discourse Studies and Multimodality with a particular attention to the representations of pathologized female appearance.  Currently, her teaching of language in literary texts has fanned the flame of her interest in Literature and Stylistics.  Alongside her academic engagements, she hopes to contribute to the preservation of mother tongues, focusing on the 'Foochow' dialect.  She welcomes research collaboration with scholars, policy makers, NGOs, Institutions and graduate/postgraduate hopefuls who would be keen to work on the aforementioned areas.

I am currently a Senior Lecturer at the Department of Science and Technology Studies, Faculty of Science, University Malaya; currently teaching Policy and Management of Sustainable Development, Sociology of Science and Research Methodology. My current research interests revolves around: Responsible Research and Innovation: Embedding Reflexivity and Social Desirability for more sustainable outcomes in Research and Innovation; Applied Scientometrics for Decision Making: Tracking and foresighting scientific and technological trends in Sustainable Development for Research Policy and Strategy; and, Science Communication: Studying Stakeholder Engagement in Science and Technology Roadmapping for Sustainable Development. My research expertise focuses on comparative case studies as well as secondary data analysis of policies, research strategies and innovation systems at the sectoral levels for Agriculture (rice, palm oil, etc.), Herbal Medicine, and Renewable Energy (hydrogen, solar, etc.). I have been involved in consultation projects such as the National Bibliometric Report 2015, and STI Indicators Report 2016. I was also the Principal Investigator for the FRGS project on "Feasibility of Smart Agriculture in ASEAN: Investigating Social Dimensions and Policy Mechanisms to Enhance Technology Adoption and Upgrading in the Rice Sector." My previous lecturing experience was in UOW Malaysia KDU University College where I was involved in leading Postgraduate by Research programmes and Research Management. Prior to my PhD, I was in Corporate Communications and Journalism specifically in the Pharma/Biotech sector, as well as in providing Analytics and Media Monitoring services at Meltwater News.  

Dr. Md Jasim Uddin obtained his PhD in Pharmaceutical Sciences from the University of Greenwich, UK. Dr. Uddin has more than 12 years of experience in the areas of Pharmaceutics, Drug Delivery and Formulation Science. His research is mainly focused on the development of transdermal microneedle arrays (using 3D printing or moulding) for the transdermal delivery of active substances (e.g., small molecules or macromolecules). Due to his industrial experiences as a Formulation Scientist, at the Department of Drug Product Design, and the Worldwide Research & Development Unit at Pfizer UK, he also has a strong background in formulation, material sciences and characterization. He has established a strong collaborative network with colleagues in several UK-based academic institutions such as the Queen’s University of Belfast, and the Universities of Kent, Strathclyde and Greenwich. Furthermore, Dr. Uddin has received significant recognition through several poster and presentation awards (e.g., CRS Annual Meeting, PharmSci) over the last few years. As a part of his management & leadership experiences, he has contributed to the organization of several international conferences. He won the Young research scholar award (2022) from the World Academy of Sciences (TWAS), UNESCO, the Young Promising Researcher Award (2020) in the ICIBLS, Inventor I & Young Inventor Award (2020) in PHARM-IIDEx, Malaysia etc. He is a scientific advisor of the Drug Delivery & Therapeutics (An non-profit organization to promote science for research, innovation & technology transfer) and has actively played his role in the Special Issue, Recent Advances in Vaccine Delivery 2022, Pharmaceutics, MDPI (Guest Editor), Expert Opinion on Drug Delivery, Taylor & Francis Group, Signal Transduction and Targeted Therapy, Springer Nature Publishers etc.